CAR T CELL THERAPY METHOD

The disclosure provides a method of preconditioning a subject for chimeric antigen receptor (CAR) T cell therapy. The method comprises administering to the subject a composition comprising a nanoparticle comprising a positively-charged surface and an interior comprising (i) a core and (ii) at least two nucleic acid layers, wherein each nucleic acid layer is positioned between a cationic lipid bilayer, at least one day prior to administering CAR T cell therapy to the subject. The disclosure also provides a method of treating a solid tumor in a subject, the method comprising administering to a subject comprising a surface antigen negative solid tumor a first composition comprising the nanoparticle, wherein the nucleic acid within the nanoparticle encodes the surface antigen, and a second composition comprising a CAR T cell that targets the surface antigen..

Medienart:

Patent

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Europäisches Patentamt - (2024) vom: 13. März Zur Gesamtaufnahme - year:2024

Sprache:

Englisch

Beteiligte Personen:

SAYOUR ELIAS [VerfasserIn]
HUANG JIANPING [VerfasserIn]
MENDEZ-GOMEZ HECTOR RUBEN [VerfasserIn]
CASTILLO CARO PAUL ANTONIO [VerfasserIn]
LIU RUIXUAN [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2024-03-13, Last update posted on www.tib.eu: 2024-03-26, Last updated: 2024-03-29

Patentnummer:

EP4333811

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA001388819